Lymphoma
May 16, 2022
We propose an efficient method to modify B-cell derived EVs by loading them with a nanotherapeutic stimuli-responsive cargo and equipping them with antibodies for efficient targeting of lymphoma cells...
Apr 25, 2022
Primary central nervous system lymphoma (PCNSL) is a form of extranodal non-Hodgkin's B-cell lymphoma limited to the CNS. The treatment of PCNSL is ineffective partly due to the blood-brain barrier (B...
Apr 18, 2022
High rates of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients and life-threatening side effects associated with immunochemotherapy make an urgent need to develop new therapies f...
Apr 18, 2022
Lymphomas, or cancers of the lymphatic system, account for around half of all blood cancers diagnosed each year. Lymphoma is a condition that is difficult to diagnose, and accurate diagnosis is critic...
Apr 11, 2022
CD19-directed chimeric antigen receptor T cells (CARÂ T) are approved for treatment of adults with relapsed/refractory diffuse large B cell lymphoma (DLBCL) following at least two lines of therapy.Thi...
Apr 11, 2022
Cytogenetic studies have played a crucial role in the discovery of genes involved in several diseases. In the field of oncohematology, cytogenetics is still necessary for the classification and progno...
Apr 04, 2022
Cutaneous T-cell lymphoma (CTCL) patients often suffer from recurrent skin infections and profound immune dysregulation in advanced disease. The gut microbiome has been recognized to influence cancers...
Mar 21, 2022
Diffuse large B-cell lymphoma (DLBCL) is characterized by clinical and molecular heterogeneity; however, this heterogeneity is rarely taken into account by standard-of-care treatment approaches. While...
Mar 14, 2022
LncRNA ZFPM2-AS1 has been illuminated to function as a carcinogenic driver in various human cancers. Whereas, the role of ZFPM2-AS1 in nasopharyngeal carcinoma (NPC) remains puzzled. To further unders...
Mar 07, 2022
Cutaneous T-cell lymphoma is a rare cancer of skin-homing T-cells. A subgroup of patients develops large cell transformation with rapid progression to an aggressive lymphoma. Here, we investigated the...
Mar 07, 2022
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive, rare lymphoma of natural killer (NK) cell origin with poor clinical outcomes. Here we used phenotypic and molecular profiling, inclu...
Feb 21, 2022
A prospective, observational, US-based study (PROVe) used three questionnaires (Pruritus-VAS, Skindex-29, MF/SS-CTCL QoL) to assess quality of life in patients diagnosed with mycosis fungoides cutaneo...
Feb 14, 2022
Plasmablastic lymphoma (PBL) is a rare subtype of large B-cell lymphoma commonly associated with HIV infection. HIV-related PBL has a dismal prognosis. The aggressive clinical course of the disease ma...
Feb 14, 2022
Copper (Cu) is an essential micronutrient that is required by all living organisms. However, Cu can also be a potentially toxic metal if excessive dietary supplementation occurs. The current study aim...
Feb 07, 2022
Human T-Cell Lymphotropic Virus Types 1 and 2 (HTLV-1/2) are delta retroviruses. HTLV-1 may lead to complications including adult T-cell leukemia-lymphoma (ATLL) and HTLV-1-associated myelopathy (HAM)...
Jan 31, 2022
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, is an aggressive and biologically heterogeneous disease. Risk stratification and treatment algorithms vary based...
Jan 31, 2022
Burkitt Lymphoma (BL) and Diffuse Large B-Cell Lymphoma (DLBCL) are aggressive B-Cell Non-Hodgkin Lymphomas (B-NHL) with a generally favorable prognosis after immunochemotherapy. The outcome of BL is ...
Jan 24, 2022
Proteins secreted by cells play significant roles in mediating many physiological, developmental, and pathological processes due to their functions in intra/intercellular communication and signaling. ...
Jan 10, 2022
Thymic stromal lymphopoietin (TSLP), a type I cytokine belonging to the IL-2 cytokine family, promotes Th2-mediated inflammatory responses. The aim of this study is to investigate whether TSLP increas...
SUB SPECIALTIES
- Oncology / Hematology General
- Therapeutic Spotlight: eNSCLC
- Therapeutic Spotlight: Gynecologic Cancers
- Therapeutic Spotlight: Renal Cell Carcinoma
- Brain Cancer Oncology
- Breast Cancer Oncology
- Cervical Cancer
- Chemotherapy
- Colon Cancer
- Hematology
- Leukemia
- Lung Cancer
- Lymphoma
- Myleoma
- Ovarian Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Skin Cancer